No Data
No Data
Small-cap Stocks Have Climbed Recently. Here Are the Ones Most Poised for Further Upside
Aquestive Therapeutics: A Buy Rating on Underappreciated Market Potential and Innovative Pipeline
Express News | Aquestive Therapeutics Inc : Leerink Partners Raises Target Price to $10 From $8
Market Participants Recognise Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Revenues Pushing Shares 37% Higher
Aquestive Therapeutics Outlines Growth and Product Progress
Express News | Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27TH